Show simple item record

dc.creatorZygogianni, A.en
dc.creatorKouloulias, V.en
dc.creatorKyrgias, G.en
dc.creatorArmpilia, C.en
dc.creatorAntypas, C.en
dc.creatorTheodorou, K.en
dc.creatorKouvaris, J.en
dc.date.accessioned2015-11-23T10:55:29Z
dc.date.available2015-11-23T10:55:29Z
dc.date.issued2013
dc.identifier10.1016/j.clbc.2013.02.007
dc.identifier.issn1526-8209
dc.identifier.urihttp://hdl.handle.net/11615/35041
dc.description.abstractThe application of the tumor bed boost by using 2 different hypofractionated planning techniques permit more efficient use of resources in hospitals. The evaluation of the radiation toxicity and the efficacy of the 2 schedules were well tolerated and effective. However, the sequential boost appears superior to the concomitant boost in terms of skin toxicity. Aim: Evaluation of related radiation toxicity and efficacy in terms of local control of 2 radiotherapeutic hypofractionated schedules in the application of tumor bed boost by using 2 different planning techniques. Method: Eighty-one patients with stage I-II disease were retrospectively selected with either concomitant (group A) or sequential (group B) boost for the tumor bed. In group A, 27 patients were treated with a total dose of 46 Gy to the whole breast and 54 Gy to the tumor bed in 20 concomitant fractions. In group B, 54 patients were treated with a total dose of 42.4 Gy in 16 fractions to the whole breast and 53 Gy to the tumor bed by 4 sequential fractions. The boost was administered with multiple photon-beam fields. The median follow-up time was 24 months. Results: The statistical analysis for the 2 groups of the study showed that skin toxicity was significantly worse in group A (P < .05, Kruskal-Wallis H test). For groups A and B at the completion of radiation therapy, grade 1 skin toxicity was observed in 18/27 patients (66.6%) and 13/54 patients (24.1%), respectively, whereas grade 2/3 was observed in 9/27 patients (33.3%) vs. 5/54 patients (9.3%), respectively (P < .001). One year after irradiation, in group A and in group B, the skin toxicity was of grade 1 in 6/27 patients (22.2%) vs. 2/54 patients (3.7%), respectively (P = .008). Within 2 years, the breast returned to its original form in all patients. No patient showed local disease recurrence. Conclusions: The accelerated hypofractionated schedules in the application of the tumor bed boost by using the 2 different planning techniques appears to be effective and well tolerated.en
dc.source.uri<Go to ISI>://WOS:000321239600010
dc.subjectBreast canceren
dc.subjectConcomitanten
dc.subjectRadiotherapyen
dc.subjectSequentialen
dc.subjectToxicityen
dc.subjectTumoren
dc.subjectbeden
dc.subjectBREAST-CONSERVING TREATMENTen
dc.subjectRANDOMIZED-TRIALen
dc.subjectCANCER RADIOTHERAPYen
dc.subjectCONSERVATIVE TREATMENTen
dc.subjectINTENSITY MODULATIONen
dc.subjectCONCOMITANT BOOSTen
dc.subjectELECTRON BOOSTen
dc.subjectACUTE TOXICITYen
dc.subjectLOCAL-CONTROLen
dc.subjectI-IIen
dc.subjectOncologyen
dc.titleComparison of Two Radiotherapeutic Hypofractionated Schedules in the Application of Tumor Bed Boosten
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record